To L - Search Results

1

Outcomes associated with apixaban vs warfarin in patients with renal dysfunction.

Hanni C, Petrovitch E, Ali M, Gibson W, Giuliano C, Holzhausen J, Makowski C, Pallisco A, Patel N, Sutter D, To L, Yost R. Hanni C, et al. Among authors: to l. Blood Adv. 2020 Jun 9;4(11):2366-2371. doi: 10.1182/bloodadvances.2019000972. Blood Adv. 2020. PMID: 32463871 Free PMC article.

2

Safety and Efficacy of a Percutaneously Inserted Ventricular Support Device Purge Solution Heparin 25 U/mL.

Jiang C, Stuart M, Makowski C, Jennings DL, To L. Jiang C, et al. Among authors: to l. Ann Pharmacother. 2021 Feb;55(2):174-180. doi: 10.1177/1060028020944831. Epub 2020 Aug 1. Ann Pharmacother. 2021. PMID: 32741200

3

Scoring big: Aligning inpatient clinical pharmacy services through implementation of an electronic scoring system.

Patel N, To L, Griebe K, Efta J, Knoth N, Johnson J, Fitzmaurice MG, Bajwa M, Stuart M, Procopio V, Stine J, MacDonald NC, Peters M, Ratusznik M, Kalus J. Patel N, et al. Among authors: to l. Am J Health Syst Pharm. 2024 Mar 7;81(6):226-234. doi: 10.1093/ajhp/zxad313. Am J Health Syst Pharm. 2024. PMID: 38070494

4

Impact of a Pharmacist-Directed Anticoagulation Service on the Quality and Safety of Heparin-Induced Thrombocytopenia Management.

To L, Schillig JM, DeSmet BD, Kuriakose P, Szandzik EG, Kalus JS. To L, et al. Ann Pharmacother. 2011 Feb;45(2):195-200. doi: 10.1345/aph.1P503. Ann Pharmacother. 2011. PMID: 21304024

5

Incidence of Heparin-Induced Thrombocytopenia in Patients With Newly Implanted Mechanical Circulatory Support Devices.

To L, Attar D, Lines B, McCarty M, Nemeh H, Lopez-Plaza I, Smith Z, Coba V, Lekura J. To L, et al. Ann Pharmacother. 2022 May;56(5):565-571. doi: 10.1177/10600280211038705. Epub 2021 Aug 12. Ann Pharmacother. 2022. PMID: 34382428

6

Epidemiology and outcomes associated with anemia during long-term support with continuous-flow left ventricular assist devices.

Jennings DL, Wagner JL, To L, Nemerovski CW, Kalus JS, Morgan JA, Lanfear DE. Jennings DL, et al. Among authors: to l. J Card Fail. 2014 Jun;20(6):387-91. doi: 10.1016/j.cardfail.2014.04.012. Epub 2014 Apr 13. J Card Fail. 2014. PMID: 24732723

7

Anticoagulation of Percutaneous Ventricular Assist Device Using Argatroban-Based Purge Solution: A Case Series.

Blum EC, Martz CR, Selektor Y, Nemeh H, Smith ZR, To L. Blum EC, et al. Among authors: to l. J Pharm Pract. 2018 Oct;31(5):514-518. doi: 10.1177/0897190017727191. Epub 2017 Aug 23. J Pharm Pract. 2018. PMID: 28830286

8

Argatroban dosing requirements in extracorporeal life support and other critically ill populations.

Dingman JS, Smith ZR, Coba VE, Peters MA, To L. Dingman JS, et al. Among authors: to l. Thromb Res. 2020 May;189:69-76. doi: 10.1016/j.thromres.2020.02.021. Epub 2020 Feb 27. Thromb Res. 2020. PMID: 32182522

9

Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab.

Morrison AR, Johnson JM, Griebe KM, Jones MC, Stine JJ, Hencken LN, To L, Bianchini ML, Vahia AT, Swiderek J, Ramesh MS, Peters MA, Smith ZR. Morrison AR, et al. Among authors: to l. J Autoimmun. 2020 Nov;114:102512. doi: 10.1016/j.jaut.2020.102512. Epub 2020 Jul 3. J Autoimmun. 2020. PMID: 32646770 Free PMC article.

10

Optimizing anticoagulation for patients receiving Impella support.

Beavers CJ, DiDomenico RJ, Dunn SP, Cox J, To L, Weeks P, Trujillo TC, Jennings DL. Beavers CJ, et al. Among authors: to l. Pharmacotherapy. 2021 Nov;41(11):932-942. doi: 10.1002/phar.2629. Epub 2021 Nov 9. Pharmacotherapy. 2021. PMID: 34597429 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters